Tachykinin receptor antagonist - Sankyo
Alternative Names: Tachykinin receptor antagonist - SankyoLatest Information Update: 17 Dec 2003
At a glance
- Originator Sankyo
- Class
- Mechanism of Action Tachykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 17 Dec 2003 No development reported - Preclinical for Asthma in Japan (PO)
- 14 Dec 1999 Preclinical development for Asthma in Japan (PO)